Impact of Neurochecks on Sleep in Critically Ill Adults
1 other identifier
interventional
30
1 country
1
Brief Summary
Background: Following acute brain injury (ABI), patients are monitored in the intensive care unit (ICU) where providers rely on frequent neurological examinations ("neurochecks") to assess for neurodeterioration. Serial neurochecks are part of guideline recommendations, but there is equipoise between hourly (Q1) and every-other-hour (Q2) evaluation. In the ICU, care-related awakenings occur frequently, but it is unclear if differential neurocheck frequencies result in differential sleep, providing the scientific premise for this proposal. Population: Thirty patients (N=15 per group) who have undergone elective aneurysm coiling will be enrolled. On post-operative day (POD) 0, patients will be screened and approached for informed consent if they do not meet exclusion criteria, e.g., prior intracranial injury, sleep disorders, cognitive impairment, mechanical ventilation. Patients with elective aneurysm coiling are being chosen because they require ICU level of care following their intracranial procedure, but do not have structural brain injury or ongoing sedation needs that might impact sleep measurements. Methods: Usual care: Patients are monitored every 15-30 minutes for up to 6 hours post-procedure, then Q1 or Q2 for up to 24 hours. If these patients remain stable, they are discharged home on post-operative day (POD) 1. Proposed Intervention: Enrolled patients will be randomized to Q1 or Q2 neurochecks following the institutionally required 6 hours of stable neurological and vascular checks. Once randomized, patients will undergo placement of electroencephalogram (EEG) with video, electrooculogram, and chin lead. The video EEG will be in place for at least 8 hours to include the overnight (10PM-6AM) time period. Following completion of the recording, the signals obtained will be reviewed by a blinded polysomnographic sleep technician for sleep characteristics including quantitative assessments of wakefulness, deep (N3) sleep, REM sleep, sleep efficiency, and sleep fragmentation and arousals. On POD1, patients and their nurse will fill out the Richards-Campbell Sleep Questionnaire to rate subjective sleep quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 18, 2023
CompletedStudy Start
First participant enrolled
August 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2028
ExpectedFebruary 9, 2026
March 1, 2025
2.4 years
May 1, 2023
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sleep efficiency
Ratio of total sleep time compared to time in bed, reported as a percentage
Within 24 hours of enrollment
Secondary Outcomes (5)
Wakefulness
Within 24 hour of enrollment
REM Sleep
Within 24 hour of enrollment
Deep Sleep
Within 24 hour of enrollment
Arousals
Within 24 hour of enrollment
Sleep quality (subjective)
Within 24 hour of enrollment
Study Arms (2)
Hourly Neurochecks
ACTIVE COMPARATORPatients awakened for neurological exams every hour
Every-Other-Hour Neurochecks
ACTIVE COMPARATORPatients awakened for neurological exams every-other-hour
Interventions
Randomized to hourly or every-other-hour examinations
Eligibility Criteria
You may qualify if:
- a. Adult patients who are status post uncomplicated elective coiling of unruptured cerebral aneurysm.
You may not qualify if:
- Patients with past or current intracranial injury or disease.
- Patients with known flow-limiting pathology of carotid arteries, vertebral arteries, or intracranial arteries.
- Incomplete resolution of aneurysm.
- Known sleep disorders (e.g., insomnia)
- Pregnancy.
- Incarceration.
- Inability to communicate in English
- Cognitive impairment or lack of decision-making capacity.
- Ongoing sedation.
- Mechanical ventilation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC San Diego Health
San Diego, California, 92130, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor of Neurosciences
Study Record Dates
First Submitted
May 1, 2023
First Posted
May 18, 2023
Study Start
August 11, 2023
Primary Completion
January 6, 2026
Study Completion (Estimated)
October 1, 2028
Last Updated
February 9, 2026
Record last verified: 2025-03